General Info

ACCESS Oncology is a privately held, cancer-focused biotechnology company. The company focuses on acquiring, developing and marketing novel therapeutics for cancer and related conditions. It maintains a portfolio of proprietary anti-cancer product candidates through the in-licensing and acquiring of clinical-stage product candidates from emerging biotechnology companies. The company is a part of Keryx Biopharmaceuticals, which is a publicly owned company that develops and acquires products for the treatment of diseases, such as diabetes and cancer.